May 15, 2018 02:38 PM EDT
Financing
Startups

Seat­tle's Nohla clos­es $45M to bring nov­el stem cell treat­ment for leukemia to late-stage tri­als

Brittany Meiling

Seat­tle’s Nohla Ther­a­peu­tics, a biotech start­up spun out of the Fred Hutchin­son Can­cer Re­search Cen­ter, has raised $45 mil­lion in new mon­ey to push for­ward …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times